期刊: BLOOD ADVANCES, 2022; 6 (15)
The critical role of G protein-coupled receptor kinase 2 (GRK2) in regulating cardiac function has been well documented for > 3 decades. Targeting ......
期刊: BLOOD ADVANCES, 2022; 6 (17)
The short life span of platelets is a major challenge to platelet transfusion services because of the lack of effective intervention. Here, we found t......
期刊: BLOOD ADVANCES, 2022; 6 (6)
The non-germinal center B-cell like (non-GCB) subtype of diffuse large B-cell lymphoma (DLBCL) has poor clinical outcomes. Bruton tyrosine kinase (BTK......
期刊: BLOOD ADVANCES, 2022; 6 (2)
Single-cell analysis is of significant importance in delineating the exact phylogeny of the subclonal population and in discovering subtle diversifica......
期刊: BLOOD ADVANCES, 2022; 6 (14)
Intracranial hemorrhage (ICH) is a rare and life-threatening hemorrhagic event in patients with immune thrombocytopenia (ITP). However, its mortality ......
期刊: BLOOD ADVANCES, 2022; 6 (3)
Single antigen-targeted chimeric antigen receptor (CAR) T-cell therapy maybe insufficient to induce a durable response in pediatric aggressive B-cell ......
期刊: BLOOD ADVANCES, 2022; 6 (9)
Hepatitis B virus (HBV) infection has been associated with an increased risk for B-cell lymphomas. We previously showed that 20% of diffuse large B-ce......
期刊: BLOOD ADVANCES, 2022; 6 (1)
The malignant plasma cell clone in patients with multiple myeloma (MM) is represented by the production of paraprotein, usually a single abnormal uniq......
期刊: BLOOD ADVANCES, 2022; 6 (8)
Epigenetic alterations, including histone acetylation, contribute to the malignant transformation of hematopoietic cells and disease progression, as w......
期刊: BLOOD ADVANCES, 2022; 6 (15)
Early hemorrhagic death is still the main obstacle for the successful treatment of acute promyelocytic leukemia (APL). However, the mechanisms underly......
期刊: BLOOD ADVANCES, 2022; 6 (13)
Inflammation contributes to the initiation and disease progression of several lymphoid malignancies. BCR-ABL1-positive B-cell acute lymphoblastic leuk......
期刊: BLOOD ADVANCES, 2022; 6 (13)
Lymphoplasmacytic lymphoma/Waldenstroeurom macroglobulinemia (LPL/WM) is a heterogeneous disease in which the role of immunoglobulin heavy-chain genes......
期刊: BLOOD ADVANCES, 2022; 6 (18)
Chromosomal aberrations and gene mutations have been considered to be the major reasons for high recurrence rates and poor survival among acute myeloi......